15
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection

      research-article
      1 , 14 , , 1 , 2 , 1 , 3 , 4 , 1 , 5 , 6 , 7 , 8 , 9 , 10 , 1 , 1 , 1 , 1 , 1 , 1 , 1 , 1 , 1 , 11 , 5 , 4 , 6 , 1 , 1 , 12 , 1 , 3 , 7 , 2 , 1 , 13 , 15 , 16 , ∗∗
      Med (New York, N.y.)
      Cell Press
      hepcidin, iron, hypoferremia, vaccination, immunometabolism, infection, influenza virus, global health, adaptive immunity, T-cells

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Background

          How specific nutrients influence adaptive immunity is of broad interest. Iron deficiency is the most common micronutrient deficiency worldwide and imparts a significant burden of global disease; however, its effects on immunity remain unclear.

          Methods

          We used a hepcidin mimetic and several genetic models to examine the effect of low iron availability on T cells in vitro and on immune responses to vaccines and viral infection in mice. We examined humoral immunity in human patients with raised hepcidin and low serum iron caused by mutant TMPRSS6. We tested the effect of iron supplementation on vaccination-induced humoral immunity in piglets, a natural model of iron deficiency.

          Findings

          We show that low serum iron (hypoferremia), caused by increased hepcidin, severely impairs effector and memory responses to immunizations. The intensified metabolism of activated lymphocytes requires the support of enhanced iron acquisition, which is facilitated by IRP1/2 and TFRC. Accordingly, providing extra iron improved the response to vaccination in hypoferremic mice and piglets, while conversely, hypoferremic humans with chronically increased hepcidin have reduced concentrations of antibodies specific for certain pathogens. Imposing hypoferremia blunted the T cell, B cell, and neutralizing antibody responses to influenza virus infection in mice, allowing the virus to persist and exacerbating lung inflammation and morbidity.

          Conclusions

          Hypoferremia, a well-conserved physiological innate response to infection, can counteract the development of adaptive immunity. This nutrient trade-off is relevant for understanding and improving immune responses to infections and vaccines in the globally common contexts of iron deficiency and inflammatory disorders.

          Funding

          Medical Research Council, UK

          Graphical Abstract

          Highlights

          • Low serum iron caused by hepcidin impairs primary and memory immune responses

          • Activated T-cells demand iron and iron scarcity inhibits mitochondrial metabolism

          • Patients with mutant TMPRSS6 have high hepcidin and lower IgG against pathogens

          • High hepcidin during viral infection inhibits T- and B-cells and inflames disease

          Context and Significance

          Iron deficiency is very common in humans and animals. Frost et al demonstrate that low concentrations of iron in serum, caused by the hormone hepcidin, inhibit the body’s response to vaccines and infections; conversely, increasing iron can boost immunity.

          Abstract

          Iron deficiency is very common in humans and animals. Frost et al. demonstrate that low concentrations of iron in serum, caused by the hormone hepcidin, inhibit the body’s response to vaccines and infections; conversely, increasing iron can boost immunity.

          Related collections

          Most cited references59

          • Record: found
          • Abstract: found
          • Article: not found

          Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

          Summary Viral pandemics, such as the one caused by SARS-CoV-2, pose an imminent threat to humanity. Because of its recent emergence, there is a paucity of information regarding viral behavior and host response following SARS-CoV-2 infection. Here we offer an in-depth analysis of the transcriptional response to SARS-CoV-2 compared with other respiratory viruses. Cell and animal models of SARS-CoV-2 infection, in addition to transcriptional and serum profiling of COVID-19 patients, consistently revealed a unique and inappropriate inflammatory response. This response is defined by low levels of type I and III interferons juxtaposed to elevated chemokines and high expression of IL-6. We propose that reduced innate antiviral defenses coupled with exuberant inflammatory cytokine production are the defining and driving features of COVID-19.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            COVID-19: immunopathology and its implications for therapy

            Xuetao Cao (2020)
            Severe coronavirus disease 2019 (COVID-19) is characterized by pneumonia, lymphopenia, exhausted lymphocytes and a cytokine storm. Significant antibody production is observed; however, whether this is protective or pathogenic remains to be determined. Defining the immunopathological changes in patients with COVID-19 provides potential targets for drug discovery and is important for clinical management.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.

              E Németh (2004)
              Hepcidin is a peptide hormone secreted by the liver in response to iron loading and inflammation. Decreased hepcidin leads to tissue iron overload, whereas hepcidin overproduction leads to hypoferremia and the anemia of inflammation. Ferroportin is an iron exporter present on the surface of absorptive enterocytes, macrophages, hepatocytes, and placental cells. Here we report that hepcidin bound to ferroportin in tissue culture cells. After binding, ferroportin was internalized and degraded, leading to decreased export of cellular iron. The posttranslational regulation of ferroportin by hepcidin may thus complete a homeostatic loop: Iron regulates the secretion of hepcidin, which in turn controls the concentration of ferroportin on the cell surface.
                Bookmark

                Author and article information

                Contributors
                Journal
                Med (N Y)
                Med (N Y)
                Med (New York, N.y.)
                Cell Press
                2666-6359
                2666-6340
                12 February 2021
                12 February 2021
                : 2
                : 2
                : 164-179.e12
                Affiliations
                [1 ]MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK
                [2 ]Food and Nutritional Sciences, School of Chemistry, Food, and Pharmacy, University of Reading, Reading, UK
                [3 ]Division of Virus-Associated Carcinogenesis (F170), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany
                [4 ]ETH Zurich, Human Nutrition Laboratory, Institute of Food, Nutrition, and Health, Zurich, Switzerland
                [5 ]Centre for Tropical Medicine and Global Health, and Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK
                [6 ]Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
                [7 ]Department of Pathology, Boston Children’s Hospital and Harvard Medical School, Boston, MA, USA
                [8 ]Instituto de Biologia Molecular e Celular & Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Porto, Portugal
                [9 ]Faculty of Medicine (FMUP) and Institute of Molecular Pathology and Immunology (IPATIMUP), University of Porto, Porto, Portugal
                [10 ]Radcliffe Department of Medicine, University of Oxford and John Radcliffe Hospital, Oxford, UK
                [11 ]School of Biological Sciences, University of Reading, Reading, UK
                [12 ]The Jenner Institute, University of Oxford, Oxford, UK
                [13 ]Haematology Theme, Oxford Biomedical Research Centre, Oxford, UK
                Author notes
                []Corresponding author joe.frost@ 123456imm.ox.ac.uk
                [∗∗ ]Corresponding author alexander.drakesmith@ 123456imm.ox.ac.uk
                [14]

                Twitter: @JoeNFrost

                [15]

                Twitter: @Drakesmith_Lab

                [16]

                Lead Contact

                Article
                S2666-6340(20)30021-0
                10.1016/j.medj.2020.10.004
                7895906
                33665641
                78cd33fd-2621-49b7-a527-bfb3b671d45f
                © 2020 The Authors

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 1 July 2020
                : 26 September 2020
                : 16 October 2020
                Categories
                Clinical and Translational Article

                hepcidin,iron,hypoferremia,vaccination,immunometabolism,infection,influenza virus,global health,adaptive immunity,t-cells

                Comments

                Comment on this article